Leerink upgraded Tandem Diabetes to Outperform from Market Perform with a $45 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes price target raised to $40 from $37 at Stifel
- Tandem Diabetes price target raised to $38 from $31 at Citi
- Reddit initiated, Seagate upgraded: Wall Street’s top analyst calls
- Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption
- Tandem Diabetes upgraded to Buy from Hold at Stifel